TCL Archive New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science January 8, 1999
TCL Archive Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology April 5, 2002